SMMT
Summit Therapeutics Inc.
+0.68 (+3.93%)17.98USD2.5M成交股數–市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-10-19下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。外國發行人(20-F)通常只申報半年或年度,逐季會有缺。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | 0.00 | – | – | 0.00 | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 158M | 133M | 131M | 208M | 51.3M | 51.4M | 37.7M | 30.8M | 30.9M | 15.3M | 9.5M | 9.9M |
| 銷售管理費用 | 62.8M | 62.6M | 103M | 360M | 15.6M | 14.2M | 20.7M | 13.8M | 11.5M | 5.4M | 6.3M | 6.9M |
| 營業利益 | – | – | – | – | – | −65.6M+220% | −58.4M+270% | −59.6M-89% | −42.4M | −20.5M | −15.8M | −537M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −216M+243% | −189M+210% | −232M+312% | −566M+837% | −62.9M+45% | −61.2M+188% | −56.3M+282% | −60.4M-89% | −43.5M | −21.3M | −14.7M | −542M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.28+211% | -0.24+200% | -0.31+288% | -0.76+744% | -0.09+50% | -0.08+167% | -0.08+300% | -0.09-94% | -0.06 | -0.03 | -0.02 | -1.43 |
| 稀釋股數 | 778M | 775M | 743M | 743M | 738M | 719M | 727M | 708M | 702M | 698M | 698M | 378M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 419M | 107M | 239M | 298M | 212M | 105M | 93.8M | 28.4M | 61.3M | 23.8M | 42.1M | 71.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 752M | 648M | 262M | 324M | 384M | 436M | 503M | 342M | 177M | 218M | 237M | 255M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 122M | 102M | 69.5M | 64.6M | 39.5M | 46.8M | 64.9M | 147M | 133M | 119M | 118M | 121M |
| 股東權益 | 630M | 546M | 192M | 259M | 344M | 389M | 438M | 195M | 44.2M | 99.4M | 120M | 133M |
| 負債比 | 16.2% | 15.7% | 26.5% | 19.9% | 10.3% | 10.7% | 12.9% | 42.9% | 75.0% | 54.5% | 49.6% | 47.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −122M | – | – | −61.2M+103% | – | – | – | −30.1M | – | – | −13.1M |
| 資本支出 | – | 245K | – | – | 422K | – | – | – | 4K | – | – | 53K |
| 自由現金流 | – | −123M | – | – | −61.6M+104% | – | – | – | −30.1M | – | – | −13.2M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2024 年度 10-K 的分部揭露 · 年增對前一年度
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −1.1B | –% | -1.44 | −324M |
| FY2024 | 0.00 | – | −221M | –% | -0.31 | −142M |
| FY2023 | 0.00 | -100.0% | −615M | –% | -0.99 | −76.9M |
| FY2022 | 705K | -61.0% | −78.8M | -11,174.8% | -0.41 | −42.2M |
| FY2021 | 1.8M | +110.3% | −88.6M | -4,897.8% | -0.67 | −72.9M |
| FY2020 | 860K | +15.7% | −52.7M | -6,127.6% | -0.76 | −48.5M |
| FY2019 | 743K | -98.7% | −29.1M | -3,920.2% | -0.89 | −21.0M |
| FY2019 | 57.1M | – | 10.9M | 19.0% | 0.63 | −35.3M |